Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Recent consensus guidelines recommend pregabalin as a first-tier treatment for painful diabetic peripheral neuropathy (DPN). We evaluated the efficacy of pregabalin 600 mg/d (300 mg dosed BID) versus placebo for relieving DPN-associa...

Full description

Bibliographic Details
Main Authors: LaMoreaux Linda, Rosenstock Julio, Arezzo Joseph C, Pauer Lynne
Format: Article
Language:English
Published: BMC 2008-09-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/8/33

Similar Items